SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBLVN.L Regulatory News (BLVN)

  • There is currently no data for BLVN

Form 8.5 (EPT/NON-RI) Bowleven Plc

28 Feb 2012 11:35

RNS Number : 2747Y
Nomura International PLC (EPT)
28 February 2012
 



FORM 8.5 (EPT/NON-RI)

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN

EXEMPT PRINCIPAL TRADER WITHOUT RECOGNISED INTERMEDIARY ("RI") STATUS (OR WHERE RI STATUS IS NOT APPLICABLE)

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Nomura International Plc

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Bowleven Plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Corporate Broker of Dragon Oil Plc

(d) Date position held/dealing undertaken:

27 February 2012

(e) Has the EPT previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer?

Yes, Dragon Oil Plc

 

2. POSITIONS OF THE EXEMPT PRINCIPAL TRADER

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

10p ordinary

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

175,878

0.060

660

0.000

(2) Derivatives (other than options):

83,058

0.028

(3) Options and agreements to purchase/sell:

 

TOTAL:

175,878

0.060

83,718

0.028

 

 

All interests and all short positions should be disclosed.

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other executive options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

3. DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

Ordinary shares

Purchase

1,328

1.2775

Ordinary shares

Purchase

2,908

1.2825

Ordinary shares

Purchase

18,371

1.2875

Ordinary shares

Purchase

1,325

1.2900

Ordinary shares

Purchase

7,274

1.2925

Ordinary shares

Purchase

43,761

1.2950

Ordinary shares

Purchase

57,334

1.2975

Ordinary shares

Purchase

42,155

1.2988

Ordinary shares

Purchase

127,362

1.3000

Ordinary shares

Purchase

10,000

1.3025

Ordinary shares

Purchase

43,567

1.3026

Ordinary shares

Purchase

79,127

1.3050

Ordinary shares

Purchase

11,693

1.3075

Ordinary shares

Purchase

24,537

1.3100

Ordinary shares

Purchase

40,898

1.3125

Ordinary shares

Purchase

10,581

1.3150

Ordinary shares

Purchase

110,000

1.3164

Ordinary shares

Purchase

17,693

1.3175

Ordinary shares

Purchase

39,206

1.3200

Ordinary shares

Purchase

14,875

1.3225

Ordinary shares

Purchase

9,972

1.3250

Ordinary shares

Purchase

12,414

1.3275

Ordinary shares

Purchase

19,305

1.3350

Ordinary shares

Purchase

21,361

1.3375

Ordinary shares

Purchase

5,695

1.3400

Ordinary shares

Purchase

13,105

1.3425

Ordinary shares

Purchase

7,606

1.3450

Ordinary shares

Purchase

2,000

1.3475

Ordinary shares

Sale

1,445

1.2825

Ordinary shares

Sale

6,080

1.2850

Ordinary shares

Sale

12,881

1.2875

Ordinary shares

Sale

24,667

1.2900

Ordinary shares

Sale

3,555

1.2925

Ordinary shares

Sale

32,169

1.2950

Ordinary shares

Sale

130,056

1.2969

Ordinary shares

Sale

32,545

1.2975

Ordinary shares

Sale

25,815

1.3000

Ordinary shares

Sale

7,500

1.3025

Ordinary shares

Sale

56,363

1.3050

Ordinary shares

Sale

5,000

1.3075

Ordinary shares

Sale

57,356

1.3100

Ordinary shares

Sale

36,807

1.3125

Ordinary shares

Sale

67,700

1.3167

Ordinary shares

Sale

23,195

1.3175

Ordinary shares

Sale

141,568

1.3180

Ordinary shares

Sale

3,727

1.3225

Ordinary shares

Sale

10,000

1.3250

Ordinary shares

Sale

3,170

1.3275

Ordinary shares

Sale

5,738

1.3350

Ordinary shares

Sale

5,000

1.3375

Ordinary shares

Sale

2,835

1.3400

Ordinary shares

Sale

24,404

1.3425

Ordinary shares

Sale

814

1.3450

 

Total Buy - 795,453

Total Sell - 720,390

 

(b) Derivatives transactions (other than options)

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

Ordinary shares

SWAP

Increasing Short

75,063

1.2775 - 1.3475

 

(c) Options transactions in respect of existing securities

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercising

 

Class of relevant security

Product description

e.g. call option

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

The currency of all prices and other monetary amounts should be stated.

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

28/02/2012

Contact name:

Kyere Tabiri

Telephone number:

020 7102 1267

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FEOLLFVLFSITFIF
Date   Source Headline
30th Nov 20073:59 pmRNSHolding(s) in Company
29th Nov 200710:24 amRNSHolding(s) in Company
20th Nov 20071:53 pmRNSBowleven IFRS Restatement
12th Nov 20079:45 amRNSHolding(s) in Company
12th Nov 20079:41 amRNSHolding(s) in Company
12th Nov 20077:00 amRNSPreliminary Results
8th Nov 20075:28 pmRNSTotal Voting Rights
8th Nov 20079:20 amRNSHolding(s) in Company
8th Nov 20079:17 amRNSHolding(s) in Company
2nd Nov 20076:30 pmRNSHolding(s) in Company
2nd Nov 20076:23 pmRNSHolding(s) in Company
2nd Nov 20076:18 pmRNSHolding(s) in Company
2nd Nov 20076:13 pmRNSHolding(s) in Company
2nd Nov 20076:10 pmRNSHolding(s) in Company
25th Oct 200711:32 amRNSAdditional Listing
24th Oct 20074:54 pmRNSHolding(s) in Company
24th Oct 20074:42 pmRNSHolding(s) in Company
24th Oct 20074:35 pmRNSHolding(s) in Company
8th Oct 200712:44 pmRNSHolding(s) in Company
2nd Oct 200712:46 pmRNSHolding(s) in Company
17th Sep 20072:55 pmRNSHolding(s) in Company
13th Sep 20073:09 pmRNSHolding(s) in Company
13th Sep 20073:03 pmRNSHolding(s) in Company
7th Sep 200711:14 amRNSHolding(s) in Company
31st Aug 20079:26 amRNSAdditional Listing
29th Aug 20077:00 amRNSTotal Voting Rights
16th Aug 200712:48 pmRNSWebsite Address
10th Aug 20077:00 amRNSOperational Update
30th Jul 20072:46 pmRNSAdditional Listing
19th Jul 20077:00 amRNSOperational Update
12th Jul 20075:33 pmRNSHolding(s) in Company
12th Jul 200711:20 amRNSHolding(s) in Company
9th Jul 20076:15 pmRNSDirector/PDMR Shareholding
6th Jul 20076:25 pmRNSHolding(s) in Company
3rd Jul 20077:01 amRNSOperational Update
25th Jun 200710:09 amRNSHolding(s) in Company
13th Jun 20073:12 pmRNSAdditional Listing
13th Jun 20073:10 pmRNSOperational Update
29th May 200711:01 amRNSHolding(s) in Company
29th May 200710:19 amRNSHolding(s) in Company
29th May 20079:11 amRNSHolding(s) in Company
22nd May 20074:14 pmRNSDirector/PDMR Shareholding
15th May 20072:57 pmRNSDirector/PDMR Shareholding
25th Apr 20077:00 amRNSDrilling Report
23rd Apr 200712:11 pmRNSAdditional Listing
10th Apr 20077:01 amRNSFarm-out of Epameno PSC
3rd Apr 200711:21 amRNSAdditional Listing
22nd Mar 20077:01 amRNSInterim Results
21st Mar 200711:13 amRNSHolding(s) in Company
21st Mar 20078:37 amRNSOperational Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.